A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours.
Saved in:
| Title: | A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours. |
|---|---|
| Authors: | Burris, Howard A.1 (AUTHOR) howard.burris@scri.com, Berlin, Jordan2 (AUTHOR), Arkenau, Tobias3 (AUTHOR), Cote, Gregory M.4 (AUTHOR), Lolkema, Martijn P.5,6 (AUTHOR), Ferrer-Playan, Jordi7 (AUTHOR), Kalapur, Anup8 (AUTHOR), Bolleddula, Jayaprakasam9 (AUTHOR), Locatelli, Giuseppe10 (AUTHOR), Goddemeier, Thomas11 (AUTHOR), Gounaris, Ioannis12 (AUTHOR), de Bono, Johann13,14 (AUTHOR) |
| Source: | British Journal of Cancer. Apr2024, Vol. 130 Issue 7, p1131-1140. 10p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
